Bristol-Myers Squibb (BMY), Lonza Expand Manufacturing Pact Oct 30, 2014 01:01PM

Bristol-Myers Squibb Company (NYSE: BMY) and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire. Financial terms were not disclosed.

Biologic medicines that treat serious diseases are an integral part of Bristol-Myers Squibb’s specialty care portfolio and R&D pipeline. Bristol-Myers Squibb and Lonza have been collaborating since 2003 to produce commercial supplies of a biologics medicine marketed by Bristol-Myers Squibb worldwide. Currently, Lonza also produces clinical supplies of an investigational biologics medicine for Bristol-Myers Squibb.

“Our expanded relationship with Lonza is an important example of our global manufacturing strategy to meet anticipated demand for our commercial biologics portfolio and prepare to bring our late-stage clinical assets to patients by supplementing our in-house manufacturing capabilities,” said Lou Schmukler, president, Global Manufacturing & Supply, Bristol-Myers Squibb.

Lonza’s development and manufacturing facilities offer proven expression systems and established platform processes for streamlined scale-up throughout the clinical pipeline. In addition to its state-of-the-art Portsmouth facility, Lonza offers three additional clinical-to-commercial mammalian production facilities in Tuas, Singapore; Porrino, Spain; and Slough, United Kingdom.

"We are pleased to extend our relationship with Bristol-Myers Squibb for the commercial production of their innovative drug substance, said Marc Funk, COO of Lonza’s Pharma & Biotech Segment. “This reinforces Lonza’s mission to support life-saving medicines by being a reliable supplier of drug substance for our customers with high-quality commercial GMP manufacturing services delivered to the market.”


GT Advanced Technologies (GTATQ), Apple Lose Bid to Keep Declaration Under Seal - Bloomberg Oct 30, 2014 12:19PM

GT Advanced Technologies (OTCBB: GTATQ) and Apple have lost a bid to keep declaration under seal, according to Bloomberg. The judge in the case will keep pricing information under seal, but he generally unseals the executive's statement.


PDI, Inc. (PDII) Does Not See Digirad's (DRAD) Offer as 'Meaningful' Oct 30, 2014 09:31AM

PDI, Inc. (NASDAQ: PDII) has responded to the letter dated October 29, 2014 from Digirad Corporation (Nasdaq: DRAD) regarding Digirad's willingness to offer to acquire PDI by indicating that PDI is not for sale and does not view Digirad's letter to be a meaningful offer to acquire PDI.

The full text of the letter which reinforces the view of PDI and its board of directors is as follows:

October 29, 2014

Matthew G. Molchan

President and Chief Executive Officer

Digirad Corporation

1048 Industrial Court, Suite E

Suwanee, GA 30024

Dear Mr. Molchan:

I am in receipt of your letter dated October 29, 2014 regarding Digirad's willingness to offer to acquire PDI, Inc. PDI's Board of Directors has reviewed and considered your letter. PDI's Board of Directors does not consider PDI for sale and does not view your letter to be a meaningful offer to acquire PDI.

Sincerely,

Gerald P. BelleChairman of the BoardPDI, Inc.


Blue Earth, Inc. (BBLU) to Acquire Stake in PowerGenix for $10M Oct 30, 2014 09:18AM

Blue Earth, Inc. (NASDAQ: BBLU), a renewable/alternative energy and energy efficiency services company, announced today that it has closed on its agreement to acquire an equity stake in PowerGenix for $10 million payable through a combination of cash ($2 million) and Blue Earth restricted common shares (3,729,604) valued at $2.145 per share. The restricted shares are subject to a lock up/leak out agreement. Reciprocal equity ownership is designed to fund PowerGenix and maximize the working relationship between the two companies.

Blue Earth has been granted exclusive marketing rights to use the proprietary PowerGenix Nickel-Zinc ("NiZn") batteries to produce intelligent digital NiZn energy storage systems using Blue Earth's proprietary intellectual property for a number of potentially multi-billion dollar market verticals including: Stationary UPS Systems in the Data Center, Military, Telecom, Utility, Renewable Energy, Motor Start-Up, Frequency Regulation, Peak Shaving/Shifting and Demand Shifting market segments. The marketing rights are global for most market verticals.

Mr. Robert Kanode, CEO of PowerGenix, stated, "Advanced technology devices often do not take full advantage of the energy delivery capabilities of today's advanced storage batteries. As a result, advanced technologies often do not fully realize their full performance potential. This is the fundamental strength of our Blue Earth/PowerGenix relationship. Carefully crafting Blue Earth's advanced technology capabilities to PowerGenix's unique nickel zinc battery capabilities is a rare opportunity to fully optimize the performance, cost and safety of PowerGenix nickel zinc battery systems. This relationship is a ground breaking alliance within an energy storage revolution."

Dr. Johnny R. Thomas, CEO of Blue Earth, stated, "We are delighted to expand our partnership with PowerGenix through these equity and marketing agreements. Partnering with PowerGenix represents an important strategic development for Blue Earth and we look forward to developing, implementing and marketing the proprietary NiZn batteries for the benefit of our customers and shareholders in several large market verticals."


Keurig Green Mountain (GMCR), SUPERVALU INC. (SVU) Report Newly Licensed Java Delight Coffee Brand Oct 30, 2014 09:15AM

Keurig Green Mountain, Inc., (Keurig) (NASDAQ: GMCR), a leader in specialty coffee, coffee makers, teas and other beverages with its innovative brewing technology, and SUPERVALU INC. (NYSE: SVU), one of the largest grocery wholesalers and retailers in the United States, today announced that the companies will offer affordable Java Delight® brand coffee products in convenient K-Cup® packs for the Keurig® hot brewing system.

“Java Delight is a welcome addition to our Keurig brand family,” said John Whoriskey, president of U.S. sales and marketing at Keurig. “By working with SUPERVALU, we can offer shoppers across the country the value pricing and rich flavors they expect from their favorite SUPERVALU brand, all with the added convenience of the Keurig Brewed® seal, ensuring premium quality with each and every cup.”

The newly licensed Java Delight coffee brand K-Cup® packs will be offered in SUPERVALU’s company stores, which operate under the Cub Foods®, Hornbacher’s®, Shop ’n Save®, SHOPPERS® Food & Pharmacy, and Farm Fresh® banners, as well as the more than 1,800 independent stores the company serves. The Java Delight brand K-Cup® packs, which became available this month, bring together the quality and value of the Java Delight brand with the consistency and integrity of Keurig Brewed® beverages.

“At SUPERVALU, we work hard to give our customers a great experience by offering a wide assortment of quality products, including thousands of affordable private brand items,” said David Young, vice president of private brands at SUPERVALU. “With the introduction of these new K-Cup pack varieties, shoppers can enjoy the great value and delicious taste of Java Delight coffees with the convenience that Keurig delivers.”

Keurig® hot system brewers use innovative brewing technology to deliver a fresh-brewed, perfect single cup of hot or brewed over ice coffee, tea, cocoa, or fruit brews every time at just the touch of a button. With the next generation Keurig® 2.0 brewer, consumers are able to brew both a single cup and a carafe of coffee from a Keurig® brand pack. With Keurig 2.0 brewing systems, consumers continue to get the same Keurig quality, simplicity and beverage choice they expect with more than 50 brands and more than 275 beverage varieties currently available, all brewed with Keurig's new beverage-optimizing brewing technology.


More Corporate News

View Older Stories

Oct 30, 2014 09:12AM Ultragenyx Pharmaceutical (RARE) Awarded EU Orphan Drug Designation for KRN23
Oct 30, 2014 09:10AM Bristol-Myers Squibb (BMY) Nivolumab Shows Objective Response Rate of 15% in CheckMate -063 Study
Oct 30, 2014 09:05AM Clean Diesel Technologies (CDTI) Gains After Announcing Two New Patents
Oct 30, 2014 09:02AM Autodesk (ADSK) to Invest $100M in 3D Printing
Oct 30, 2014 08:56AM Chembio Diagn (CEMI) Reports DPP HIV 1/2 Assay Given CLIA Waiver From FDA
Oct 30, 2014 08:51AM Western Gas Partners LP (WES) Prices 7.5M Common Offering at $70.85/Unit
Oct 30, 2014 08:36AM Hemispherx Biopharma (HEB) Reports Evidence Based Potential of Ampligen Against Ebola
Oct 30, 2014 08:34AM Kandi Technologies Group (KNDI) to Launch Car-Share Program in Chengdu; Will Deliver 1,000 Vehicles Before End of 2014
Oct 30, 2014 08:06AM Myos Corporation (MYOS) Reports Data Showing Fortetropin's Anti-Inflammatory Properties
Oct 30, 2014 07:38AM S&T Bancorp (STBA), Integrity Bancshares Enter Merger Pact
Oct 30, 2014 07:17AM Omeros Corp. (OMER) Omidria Receives Pass-Through Status from Center for Medicare & Medicaid Services
Oct 30, 2014 06:52AM GW Pharma (GWPH) Commences Phase 2/3 Trial of Epidiolex
Oct 30, 2014 06:28AM Facebook (FB) Files 162.7M Common Shelf for WhatsApp-Related Shareholders
Oct 30, 2014 06:26AM Apple (AAPL) Smartphone Shipments Rose 16.1% in Q3; Xiaomi Breaks into Top Five - IDC (GOOG) (MSFT)
Oct 29, 2014 05:18PM Novavax (NVAX) H7N9 VLP + Matrix-M Granted FDA Fast-Track Designation
Oct 29, 2014 04:21PM FuelCell Energy (FCEL) to Expand Connecticut Facility
Oct 29, 2014 04:20PM Lakeland Industries (LAKE) Updates on Ebola Efforts; Sees 'Significant' Interest in ChemMAX, MicroMAX Lines
Oct 29, 2014 03:33PM Terex (TEX) Announces Joint Venture with Manitex International
Oct 29, 2014 03:01PM Immunomedics (IMMU) Issues Encouraging Update on IMMU-132
Oct 29, 2014 02:57PM American Realty Capital Properties (ARCP) to Hold Conference Call Today
Oct 29, 2014 02:29PM Lannett (LCI) Letrozole Tabs ANDA Approved by FDA
Oct 29, 2014 02:13PM WI-LAN (WILN) Unit to Acquire Semi Packing IP Portfolio from ROHM Co.
Oct 29, 2014 02:08PM Pfizer (PFE): First Vaccine Approved by FDA to Prevent Serogroup B Meningococcal Disease
Oct 29, 2014 01:43PM Apple (AAPL) in preliminary talks with Iran distributors for the iPhone - WSJ
Oct 29, 2014 01:34PM Bank of America's (BAC) Moynihan Said Mortgage Problems 'Behind Them'
Oct 29, 2014 12:34PM Starboard Sends Letter to RealD (RLD); Urges Reconsideration of Acquisition Proposal
Oct 29, 2014 11:59AM ATK (ATK) to Evaluate Plans on Unit Merger with Orbital (ORB) Following Rocket Disaster
Oct 29, 2014 11:55AM Twitter (TWTR), IBM (IBM) Enter Agreement on Data
Oct 29, 2014 11:55AM Twitter (TWTR), IBM (IBM) Enter Agreement on Data
Oct 29, 2014 11:47AM Axion Power (AXPW) Closes 1.88M Common, Warrants Offering
Oct 29, 2014 11:25AM BlackBerry (BBRY) CEO Chen Announces 'BlackBerry Classic'
Oct 29, 2014 11:05AM Hewlett-Packard (HPQ) Unveils 3D Printing System
Oct 29, 2014 11:05AM Hewlett-Packard (HPQ) Unveils 3D Printing System
Oct 29, 2014 09:56AM Ormat Technologies (ORA), Ormat Industries Considering Group Reorganization
Oct 29, 2014 09:52AM Vanda Pharmaceuticals (VNDA) Prices 5M Offering at $11.60/Share
Oct 29, 2014 11:05AM Hewlett-Packard (HPQ) Unveils 3D Printing System
Oct 29, 2014 09:31AM Electronics for Imaging (EFII) Acquires Key IP Assets from Polymeric Imaging
Oct 29, 2014 09:29AM Exact Sciences (EXAS) Reports Cologuard Will be Offered by Meriter-UnityPoint Health
Oct 29, 2014 09:26AM InspireMD (NSPR) MGuard Prime EPS Amended IDE Submission Approved by FDA
Oct 29, 2014 09:23AM Applied Materials (AMAT) Sees Delay in Closing Merger
Oct 29, 2014 09:12AM Metalico (MEA) Says Stock Declines Tied to Aggressive Short Selling
Oct 29, 2014 09:11AM UPDATE: Fiat Chrysler Automobiles (FCAU) Plans to Spin off Ferrari
Oct 29, 2014 09:09AM NQ Mobile (NQ) Enters Reseller Agreement with SoftBank Commerce & Service
Oct 29, 2014 09:11AM UPDATE: Fiat Chrysler Automobiles (FCAU) Plans to Spin off Ferrari
Oct 29, 2014 09:03AM UPS (UPS) Sees Peak Holiday Volume Up 11%
Oct 29, 2014 08:45AM Urstadt Biddle Properties (UBA) Prices 2.5M Common Offering at $21.30/Share
Oct 29, 2014 08:44AM FireEye (FEYE), Verizon (VZ) Enter Mobile Security Arrangement
Oct 29, 2014 08:37AM Kamada's (KMDA) Glassia Receives FDA Orphan Drug Desgination
Oct 29, 2014 08:32AM Pfizer (PFE) Reports Significant Data from PRISTIQ v. Placebo as Sexual Function Treatment in MDD
Oct 29, 2014 08:16AM Versar (VSR) Unit Awarded $3.5M AFRC Contract to Update Existing FOCUS Studies
View Older Stories